- $394.95m
- -$58.86m
- $97.67m
- 51
- 30
- 45
- 37
Annual balance sheet for Somalogic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 45.6 | 205 | 658 | 540 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 4.2 | 17.4 | 17.1 | 17 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 59.8 | 232 | 692 | 582 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 5.71 | 3.91 | 9.56 | 19.6 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 71.3 | 242 | 706 | 647 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 8.9 | 17.8 | 29.3 | 43.3 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 50.8 | 56.4 | 94.1 | 84.8 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Treasury Stock | ||||
Other Equity | ||||
Total Equity | 20.4 | 186 | 612 | 563 |
Total Liabilities & Shareholders' Equity | 71.3 | 242 | 706 | 647 |
Total Common Shares Outstanding |